Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 5/20 | 0.53 |
| ▸ | CA2 | P00918 | 5/20 | 0.53 |
| ▸ | CA9 | Q16790 | 4/20 | 0.50 |
| ▸ | TSHR | P16473 | 2/20 | 0.50 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.50 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.50 |
| ▸ | MPO | P05164 | 9/20 | 0.49 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.47 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.47 |
| ▸ | SLC6A4 | P31645 | 2/20 | 0.46 |
| ▸ | TERT | O14746 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8939973 | 0.85 | CA12 (0.74) | CA12CA2CA9TSHRKDM4E | |
| Hydrochloric Acid SCHEMBL8940039 | 0.84 | CA12 (0.71) | CA12CA2CA9TSHRKDM4E | |
| SCHEMBL12765730 | 0.82 | TSHR (0.67) | CA12CA2CA9TSHRKDM4E | |
| SCHEMBL22551107 | 0.80 | CA12 (0.56) | CA12CA2CA9TSHRKDM4E | |
| SCHEMBL15483816 | 0.77 | CA12 (0.67) | CA12CA2CA9TSHRKDM4E | |
| SCHEMBL13973324 | 0.77 | TSHR (0.54) | CA12CA2CA9TSHRKDM4E | |
| SCHEMBL17714018 | 0.73 | MPO (0.64) | CA12CA2CA9TSHRKDM4E | |
| SCHEMBL29761161 | 0.73 | MPO (0.64) | CA12CA2CA9TSHRKDM4E | |
| SCHEMBL8940036 | 0.73 | MPO (0.65) | CA12CA2CA9TSHRKDM4E | |
| SCHEMBL13186842 | 0.71 | EGFR (0.51) | CA12CA2CA9TSHRKDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3724168-B1 | NEW DAZA CHELATORS AS LIGANDS IN LIVER IMAGING | X NUCLEAR DIAGNOSTICS GMBH (DE) | 2025-07-30 | — | — | EP | disclosed |
| US-11701439-B2 | DAZA chelators as ligands in liver imaging | X-NUCLEAR DIAGNOSTICS GMBH (DE) | 2023-07-18 | — | — | US | disclosed |
| US-20210069357-A1 | NEW DAZA CHELATORS AS LIGANDS IN LIVER IMAGING | Universitätsklinikum Jena (DE) | 2021-03-11 | — | — | US | disclosed |
| EP-3724168-A1 | NEW DAZA CHELATORS AS LIGANDS IN LIVER IMAGING | Universitätsklinikum Jena (DE) | 2020-10-21 | — | — | EP | disclosed |
| CN-111630037-A | Novel DAZA chelators as ligands in liver imaging | 耶拿大学综合医院 | 2020-09-04 | — | — | CN | disclosed |
| WO-2019115429-A1 | NEW DAZA CHELATORS AS LIGANDS IN LIVER IMAGING | Universitätsklinikum Jena (DE) | 2019-06-20 | — | — | WO | disclosed |
| US-8912332-B2 | Synthesis of trivalent flexible frameworks with ligands comprising catechol units for functionalizing surfaces | JUSTUS-LIEBIG-UNIVERSITAET GIESSEN (DE) | 2014-12-16 | — | — | US | disclosed |
| EP-2428503-B1 | Synthesis of tripodal catechol derivatives with a flexible base for functionalising surfaces | Justus Liebig Universität Giessen (DE) | 2014-12-10 | — | — | EP | disclosed |
| US-20130245270-A1 | Synthesis of Trivalent Flexible Frameworks with Ligands Comprising Catechol Units for Functionalizing Surfaces | JUSTUS-LIEBIG-UNIVERSITAT GIESSEN (DE) | 2013-09-19 | — | — | US | disclosed |
| WO-2012032085-A1 | SYNTHESIS OF TRIVALENT FLEXIBLE FRAMEWORKS WITH LIGANDS COMPRISING CATECHOL UNITS FOR FUNCTIONALIZING SURFACES | JUSTUS-LIEBIG-UNIVERSITÄT GIESSEN (DE) | 2012-03-15 | — | — | WO | disclosed |
| EP-2428503-A1 | Synthesis of tripodal catechol derivatives with a flexible base for functionalising surfaces | Justus-Liebig-Universität Gießen (DE) | 2012-03-14 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130245270-A1 | Synthesis of Trivalent Flexible Frameworks with Ligands Comprising Catechol Units for Functionalizing Surfaces | CHRM3, CHRM5, CHRM4 | CA12 532/4885CA2 1639/4885CA9 830/4885 |
| US-20210069357-A1 | NEW DAZA CHELATORS AS LIGANDS IN LIVER IMAGING | DAZAP1, SLC39A11, SLC10A1 | CA12 5/4885CA2 161/4885CA9 19/4885 |
| US-11701439-B2 | DAZA chelators as ligands in liver imaging | DAZAP1, SLC39A11, SLC10A1 | CA12 5/4885CA2 178/4885CA9 21/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.